98%
921
2 minutes
20
Background And Objective: Our previous research examined the biophysical conditions required for CTC arrest using a custom-built solid-fluid 2D axisymmetric computational model. Application of that model resulted in calculating the limiting conditions under which a CTC can pass through a narrowed capillary with a platelet attached to the capillary wall. This paper is a step forward in determining the effects of a selected set of parameters: number of platelets, CTC diameter, stiffness, and ligand-receptor bond stiffness of the CTC (with or without attached platelets) on the CTC trajectory, its axial position, and its attachment to the wall. Consideration of a single CTC provides the "net" effects of platelets on CTC attachment, although, in reality, there can be many configurations of cells and platelets, leading to additional interactions and outcomes regarding metastasis. We consider cases where platelets are resting and when they are activated. The effects of platelet activation on cell attachment to the wall-and hence on metastasis-are among the main goals of this paper. Quantification of platelet activation is achieved through an original concept that connects our computational model with data from a unique experimental investigation. The selected parameters provide METHODS: : The modeling concept of the motion of the CTC and platelets within the fluid relies on a strong coupling approach with a remeshing procedure. Additionally, a 1D FE truss (rope) element is implemented to simulate active ligand-receptor bonds, including the correction of platelet-cell adhesion forces due to platelet activation, as determined experimentally.
Results: We have experimentally determined the attractive forces between cells and both non-activated and thrombin-activated platelets. The experimental results are incorporated into our computational models. This parametric study provides insight into the biomechanical conditions for CTC motion and arrest, contributing to the predictive capabilities for metastasis initiation and progression. Relationships are established between the properties of CTCs (size and stiffness), platelet size and stiffness, and ligand-receptor interaction intensity on one side, and the time in contact between CTCs and platelets, as well as the conditions for cell arrest, on the other side.
Conclusions: It is found that the number of platelets enhances the adhesion of the CTC to the wall due to effects on the fluid flow field and the overall increase in adhesion force with a higher number of platelets. Furthermore, it was found that adherence (metastasis), under otherwise identical conditions, is enhanced in the case of a softer cell. Although the 2D model simplifies real 3D conditions, it provides insight into the effects of geometrical and material parameters relevant to metastasis within capillaries in the presence of both non-activated and activated platelets.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.cmpb.2025.108699 | DOI Listing |
Stroke
September 2025
Department of Neurology, Vagelos College of Physicians and Surgeons, Columbia University, New York. (F.C.P., M.R., M.S., A.K., S.G., S.A., S.P., J.C., D.J.R.).
Background: Major ABO-incompatible platelet transfusions are associated with poor intracerebral hemorrhage (ICH) outcomes, yet drivers for this relationship remain unclear. Brain magnetic resonance imaging (MRI) ischemic lesions after ICH are neuroimaging biomarkers of secondary brain injury and are associated with poor outcomes. Given that ABO-incompatible platelet transfusions can induce immune complex formation, thrombo-inflammation, and endothelial barrier disruption, factors that could exacerbate cerebral ischemia, we explored whether major ABO-incompatible platelet transfusions are risk factors for ischemic lesions on brain MRI after ICH.
View Article and Find Full Text PDFCytometry B Clin Cytom
September 2025
School of Medical Sciences, Universidade Estadual de Campinas (Unicamp), Campinas, Brazil.
Acute promyelocytic leukemia (APL) is a medical emergency that needs immediate diagnosis and treatment. Podoplanin, a transmembrane glycoprotein that binds CLEC-2 on platelets, was recently demonstrated to be abnormally expressed in leukemic blasts in APL, as opposed to other forms of AML, in a study using thawed primary cells. This study aimed to explore and validate the diagnostic accuracy of measuring podoplanin expression by flow cytometry in the differential diagnosis of APL and other forms of acute myeloid leukemia (AML) as part of the diagnostic work-up of all cases suspected of AML in an academic hematology center.
View Article and Find Full Text PDFPhotochem Photobiol
September 2025
Universidade Estadual Do Oeste Do Paraná (UNIOESTE), Cascavel, Brazil.
The study investigated the impact of different treatments on recovery from calcaneal tendinopathy in rats, focusing on the gastrocnemius muscle. Tendinopathy is caused by repetitive overload, leading to structural collagen damage and chronic muscle inflammation. Three therapeutic approaches were compared: photobiomodulation (PBM), advanced platelet-rich fibrin (A-PRF) injection, and a combination of the two.
View Article and Find Full Text PDFRadiat Res
August 2025
Department of Radiation Medicine, College of Naval Medicine, Naval Medical University, Shanghai, China.
High-energy neutron radiation (HENR) induces severe cellular and tissue damage, yet effective prophylactic agents remain limited. In this study, the TLR2/NOD2 co-agonist CL429 was evaluated for its radioprotective potential against 14.1 MeV neutron exposure.
View Article and Find Full Text PDFScand J Trauma Resusc Emerg Med
September 2025
Department of Clinical Sciences, Malmö, Section of Surgery, Lund University, Malmö, Sweden.
Background: Antithrombotic treatment might affect bleeding symptoms, identification of bleeding source and treatment for patients with acute gastrointestinal bleeding. This study aims to investigate possible differences in initial bleeding symptoms, identified bleeding site and treatment of patients with or without antithrombotic medication admitted for gastrointestinal bleeding.
Methods: All consecutive adult patients primarily admitted for gastrointestinal bleeding at Skane University Hospital between 2018-01-01 and 2019-06-31, were included in this study.